Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor

This is the first report in which crizotinib, an anaplastic lymphoma kinase (ALK) inhibitor, reduced an atypical carcinoid tumor with ALK rearrangement. A 70-year-old man developed a tumor in the left lung and multiple metastases to the lung and brain. The pathology of transbronchial biopsied specim...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Intern Med
Main Authors: Nakajima, Masayuki, Uchiyama, Naoki, Shigemasa, Rie, Matsumura, Takeshi, Matsuoka, Ryota, Nomura, Akihiro
Format: Artigo
Sprog:Inglês
Udgivet: The Japanese Society of Internal Medicine 2016
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5140865/
https://ncbi.nlm.nih.gov/pubmed/27803410
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker